Virta Health CAIHL draft report

Virta Health: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Virta distinguishes optional patient-facing Viv conversations from background care algorithms. Members are offered a choice of Viv or a human coach. That choice does not establish the ability to refuse all AI processing or change the program’s objectives.

Scope and agency posture

Human-led metabolic program with care-team algorithms and optional patient-facing Viv. These AI functions have different degrees of patient control.

Posture: Mixed, potentially agency-expanding.

Axis: 54/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

• An official 2025 release describes Viv for nonclinical questions and says members can choose Viv or a human coach. It also describes medication cost objectives. This is official feature evidence, though announced rollout is not a live walkthrough. https://www.virtahealth.com/press/virta-health-announces-record-and-accelerating-growth

• The current clinical privacy notice discloses AI for care, monitoring and recommendations, deidentified model development, restrictions on third-party providers' own training, and clinician oversight. It documents amendment requests and says AI restrictions may be refused when they interfere with care or operations. https://www.virtahealth.com/privacypractice

Patient authority

Inference from the documented workflow: Choice between Viv and a coach is documented. That choice does not mean members can opt out of all background algorithms or change the program's clinical objectives.

Critical capacity

Editorial assessment: On-demand nonclinical guidance and human contact support practical decisions. Program-level clinical results are not evidence that AI explanations or flags are inspectable.

Informed control

Editorial assessment: The new public notice provides substantive AI information missing from the seed. Formal records rights and limits on AI restriction are more informative than app-store deletion labels alone.

Assessment and limits

The baseline understates official patient-facing AI documentation. Mixed remains supportable because user choice in Viv coexists with program-governed background AI.

Confidence: Moderate for documented functions and policy.

Remaining uncertainty: Current Viv availability, model-output correction and practical requests to restrict AI remain untested

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

• Reviewer/model: OpenAI Codex / GPT-6.
• Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
• Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
• Earlier review: 2026-06-12. Historical assessment. Earlier claims are not automatically reverified by this publication.